Index of reports
> Cases with Dyspnoea (59)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Copegus (Ribavirin) where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 59 Next >>
Possible Copegus side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-21
Patient: male
Reactions: Confusional State, Dyspnoea, Disorientation, Rash Pruritic, Loss of Consciousness, Burning Sensation, Malaise, Hypersomnia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2012-05-14
End date: 2012-07-30
Copegus
Indication: Hepatitis C
End date: 2012-07-30
Telaprevir
Indication: Hepatitis C
End date: 2012-07-30
Possible Copegus side effects in male
Reported by a consumer/non-health professional from Chile on 2012-08-20
Patient: male, weighing 84.0 kg (184.8 pounds)
Reactions: Dyspnoea, Muscular Weakness, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2012-07-20
End date: 2012-08-10
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-20
Possible Copegus side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-16
Patient: male
Reactions: Dysgeusia, Dyspnoea, Coagulopathy, Anaemia, Pulmonary Thrombosis, Factor V Deficiency, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Copegus
Dosage: zydus pharmaceutical
Indication: Hepatitis C
Start date: 2012-05-22
Pegasys
Dosage: proclick autoinjector
Indication: Hepatitis C
Start date: 2012-05-22
Possible Copegus side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-14
Patient: female
Reactions: Asthma, Weight Increased, Dyspnoea, Fatigue, Dyspnoea Exertional, Nausea, Feeling Abnormal, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Telaprevir
Indication: Hepatitis C
Start date: 2012-03-09
End date: 2012-05-25
Pegasys
Indication: Hepatitis C
Start date: 2012-03-09
Copegus
Dosage: daily divided dose
Indication: Hepatitis C
Start date: 2012-03-09
Other drugs received by patient: Fluticasone Propionate; Ventolin
Possible Copegus side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Scratch, White Blood Cell Count Decreased, Dyspnoea, Nausea, Drug Ineffective, Drug Hypersensitivity, Hyperhidrosis, Syncope, Middle Insomnia, RED Blood Cell Count Decreased, Injection Site Reaction, Dizziness, Unevaluable Event, Asthenia, Feeling Abnormal
Drug(s) suspected as cause:
Victrelis
Administration route: Oral
Copegus
Administration route: Oral
Promethazine
Peginterferon Alfa-2A
Possible Copegus side effects in female
Reported by a physician from United States on 2012-08-09
Patient: female
Reactions: Dyspnoea, Injection Site Erythema, Rash Generalised, Anaphylactic Reaction, Blister
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Copegus
Administration route: Oral
Indication: Hepatitis C
Possible Copegus side effects in male
Reported by a physician from United States on 2012-08-09
Patient: male, weighing 71.0 kg (156.2 pounds)
Reactions: Fatigue, Dyspnoea, Pancytopenia, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Dosage: most recent dose:27/apr/2012
Indication: Hepatitis C
Start date: 2012-03-30
Copegus
Dosage: most recent dose:02/may/2012
Indication: Hepatitis C
Start date: 2012-03-30
Telaprevir
Dosage: most recent dose: 02/may/2012
Indication: Hepatitis C
Start date: 2012-03-30
Other drugs received by patient: Demeclocycline HCL; Nadolol
Possible Copegus side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06
Patient:
Reactions: Nerve Injury, Cystitis Radiation, Pain, Cyst, Fatigue, Emotional Disorder, Pain in JAW, Abdominal Pain Lower, Back Pain, Blood Urine Present, Dyspnoea, Musculoskeletal Discomfort, Joint Injury, Full Blood Count Decreased, Haemoglobin Decreased, Irritability, Syncope, Arthralgia, Insomnia
Drug(s) suspected as cause:
Copegus
Administration route: Oral
Copegus
Administration route: Oral
Pegasys
Victrelis
Possible Copegus side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-03
Patient: male
Reactions: Fatigue, Dizziness, Blood Sodium Decreased, Decreased Appetite, Cough, White Blood Cell Count Decreased, Pneumonia, Dyspnoea, Haemoptysis, Nausea, Tuberculosis, Haemoglobin Decreased, Diarrhoea, Arthralgia, Sputum Discoloured, Asthenia, Influenza Like Illness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-16
Pegasys
Indication: Hepatitis C
Start date: 2012-03-16
Other drugs received by patient: Lisinopril
Possible Copegus side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-01
Patient: female
Reactions: Abdominal Pain, Thrombosis, Pruritus, Lymphadenopathy, Injection Site Haematoma, Hallucination, Auditory, Tooth Extraction, Headache, Appetite Disorder, Malaise, Menorrhagia, Skin Warm, Muscle Spasms, Blister, Crying, Back Pain, Stomatitis, Rash Erythematous, Insomnia, Swelling, Vision Blurred, Thyroid Disorder, Pain, Constipation, Fatigue, Chest Pain, Bone Disorder, Depression, Hallucination, Decreased Appetite, Blood Pressure Increased, Dyspnoea, Nausea, Musculoskeletal Pain, Rash, Anxiety, Gingival Pain, Psychotic Disorder, Lung Disorder, Oral Pain, Dysuria, Pollakiuria, Memory Impairment, Feeling Abnormal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Telaprevir
Indication: Hepatitis C
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Pegasys
Dosage: dosage reported as one injection per week.
Indication: Hepatitis C
Start date: 2004-10-30
End date: 2005-01-09
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2004-10-30
End date: 2005-01-09
Other drugs received by patient: Wellbutrin; Prozac
Possible Copegus side effects in male
Reported by a physician from United States on 2012-07-26
Patient: male, weighing 71.0 kg (156.2 pounds)
Reactions: Dyspnoea, Fatigue, Pancytopenia, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Telaprevir
Dosage: most recent dose on 02 may 2012
Indication: Hepatitis C
Start date: 2012-03-30
Pegasys
Dosage: most recent dose on 27 apr 2012
Indication: Hepatitis C
Start date: 2012-03-30
Copegus
Dosage: most recent dose on 02 may 2012
Indication: Hepatitis C
Start date: 2012-03-30
Other drugs received by patient: Nadolol; Demeclocycline HCL
Possible Copegus side effects in male
Reported by a physician from Canada on 2012-07-26
Patient: male
Reactions: Dyspnoea, Pericarditis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Blinded BI 201335 (Hcv Protease Inhibitor)
Indication: Hepatitis C
Copegus
Indication: Hepatitis C
Other drugs received by patient: Venlafaxine; Ranitidine; Meloxicam
Possible Copegus side effects in female
Reported by a physician from United States on 2012-07-25
Patient: female
Reactions: Eyelid Oedema, Renal Disorder, Dyspnoea, Hypersensitivity, Swelling Face, Rash Generalised, Anaemia, Abasia, Rash, Full Blood Count Decreased, Hospitalisation, Heart Rate Increased, Insomnia, Infusion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2012-05-03
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-03
Incivek
Indication: Hepatitis C
End date: 2012-06-21
Other drugs received by patient: Flexeril; Levothyroxine Sodium
Possible Copegus side effects in male
Reported by a consumer/non-health professional from Italy on 2012-07-18
Patient: male, weighing 58.0 kg (127.6 pounds)
Reactions: Dyspnoea, Ventricular Hypokinesia, Cardiovascular Disorder, Arrhythmia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2010-11-05
End date: 2011-04-13
Copegus
Dosage: drug name reported as copegus.
Indication: Hepatitis C
Start date: 2010-11-05
End date: 2011-04-13
Possible Copegus side effects in female
Reported by a physician from United States on 2012-07-17
Patient: female, weighing 164.0 kg (360.8 pounds)
Reactions: Dyspnoea, Dementia Alzheimer's Type, Swelling, Thyroid Disorder, Abdominal Distension, Blood Thyroid Stimulating Hormone Increased
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2011-11-16
Copegus
Indication: Hepatitis C
Start date: 2011-11-16
Possible Copegus side effects in male
Reported by a physician from United Kingdom on 2012-07-10
Patient: male, weighing 81.0 kg (178.2 pounds)
Reactions: White Blood Cell Analysis, Dyspnoea, Vomiting, Pneumonia, Pulmonary Tuberculosis, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms, Diarrhoea, Sarcoidosis, Lymphoma, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Indication: HIV Infection
Start date: 2012-03-13
End date: 2012-03-14
BI 201335 (Hcv Protease Inhibitor)
Indication: HIV Infection
Pegasys
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-03-07
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
BI 201335 (Hcv Protease Inhibitor)
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-03-14
Copegus
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-13
End date: 2012-03-14
Other drugs received by patient: Raltegravir; Citalopram Hydrobromide; Fortijuice; Acetaminophen; Metronidazole; Ciprofloxacin; Fortisip; SUN Bath Protective Tanning Lotion; Acyclovir; Truvada; Nystatin; Citalopram Hydrobromide
Possible Copegus side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-26
Patient: female
Reactions: Abdominal Pain, White Blood Cell Count Decreased, Dyspnoea, Chest Discomfort, Haemoglobin Abnormal, Constipation, Abdominal Rigidity, Diarrhoea, Palpitations, RED Blood Cell Count Decreased, Asthenia, Cough, Lethargy
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2012-02-07
Copegus
Copegus
Indication: Hepatitis C
Start date: 2012-02-07
Telaprevir
Indication: Hepatitis C
Start date: 2012-02-07
Possible Copegus side effects in male
Reported by a physician from United States on 2012-06-25
Patient: male
Reactions: Dyspnoea, Hypotension
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-06-11
Pegasys
Dosage: dose reduced
Start date: 2012-06-11
Copegus
Dosage: dose reduced
Administration route: Oral
Start date: 2012-06-11
Daclatasvir
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-11
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-06-11
Other drugs received by patient: Elavil; Amlodipine; Lorazepam; Efavirenz; Ibuprofen; Glucosamine Sulfate / Methyl Sulfonyl Methane; Procrit; Tenofovir Disoproxil Fumarate; Multi-Vitamin; Abacavir; Flomax; Prevacid; Loratadine; Flonase; Amoxicillin and Clavulanate Potassium; Lisinopril; Ketoconazole
Possible Copegus side effects in male
Reported by a physician from United Kingdom on 2012-06-15
Patient: male, weighing 81.0 kg (178.2 pounds)
Reactions: White Blood Cell Analysis, Pneumonia, Dyspnoea, Vomiting, Pulmonary Tuberculosis, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms, Diarrhoea, Sarcoidosis, Lymphoma, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
BI 201335 (Hcv Protease Inhibitor)
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-03-14
Pegasys
Indication: HIV Infection
Start date: 2012-03-13
End date: 2012-03-14
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
BI 201335 (Hcv Protease Inhibitor)
Indication: HIV Infection
Copegus
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-13
End date: 2012-03-14
Pegasys
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-03-07
Other drugs received by patient: Truvada; Raltegravir; Acetaminophen; Citalopram Hydrobromide; Metronidazole; Fortijuice; Acyclovir; Ciproflaxacin; Citalopram Hydrobromide; SUN Bath Protective Tanning Lotion; Nystatin; Fortisip
Possible Copegus side effects in female
Reported by a physician from United States on 2012-06-14
Patient: female, weighing 72.7 kg (159.9 pounds)
Reactions: Mania, Abdominal Pain, Dyspnoea, Nausea, Urinary Tract Infection, Pancreatic Cyst, Depression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Escitalopram Oxalate
Administration route: Oral
Indication: Depression
Start date: 2012-04-19
End date: 2012-04-21
Escitalopram Oxalate
Administration route: Oral
Start date: 2012-04-19
End date: 2012-04-21
Blinded Alisporivir
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-10
End date: 2012-04-17
Escitalopram Oxalate
End date: 2012-04-23
Pegasys
Indication: Hepatitis C
Start date: 2011-11-10
End date: 2012-04-18
Copegus
Dosage: 600 mg in every morning and 400 mg in every evening
Indication: Hepatitis C
Start date: 2011-11-10
End date: 2012-04-21
Possible Copegus side effects in male
Reported by a physician from United Kingdom on 2012-06-12
Patient: male, weighing 81.0 kg (178.2 pounds)
Reactions: White Blood Cell Analysis, Vomiting, Pneumonia, Dyspnoea, Pulmonary Tuberculosis, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms, Diarrhoea, Sarcoidosis, Lymphoma, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
BI 201335 (Hcv Protease Inhibitor)
Indication: HIV Infection
BI 201335 (Hcv Protease Inhibitor)
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-03-14
Pegasys
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-03-07
Copegus
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-13
End date: 2012-03-14
Pegasys
Indication: HIV Infection
Start date: 2012-03-13
End date: 2012-03-14
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
Other drugs received by patient: Acetaminophen; Citalopram; Truvada; Nystatin; Citalopram; Metronidazole; Raltegravir; Acyclovir; Ciprofloxacin; Fortisip
Possible Copegus side effects in 51 year old male
Reported by a consumer/non-health professional from Malaysia on 2012-06-08
Patient: 51 year old male
Reactions: Asthma, Dyspnoea
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2010-07-30
End date: 2011-01-07
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-07-30
End date: 2011-01-07
Possible Copegus side effects in 60 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-04
Patient: 60 year old female
Reactions: Haemoglobin Decreased, Weight Increased, Dyspnoea, Oedema Peripheral, Tachycardia, Blood Thyroid Stimulating Hormone Increased, Bronchitis, Hepatic Cirrhosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Copegus
Indication: Hepatitis C
Start date: 2011-04-01
End date: 2011-07-01
Copegus
Indication: Hepatitis C
Start date: 2006-01-01
End date: 2008-01-01
Victrelis
Dosage: 800 mg;tid;
Indication: Hepatitis C
Start date: 2012-02-09
Pegasys
Indication: Hepatitis C
Start date: 2006-01-01
End date: 2008-01-01
Pegasys
Indication: Hepatitis C
Start date: 2011-04-01
End date: 2011-07-01
Pegasys
Indication: Hepatitis C
Start date: 2012-01-02
Other drugs received by patient: Cefpodoxime Proxetil; Bronchokod; Deturgylone
Possible Copegus side effects in female
Reported by a consumer/non-health professional from United States on 2012-05-28
Patient: female
Reactions: Abdominal Pain, White Blood Cell Count Decreased, Chest Discomfort, Dyspnoea, Haemoglobin Abnormal, Abdominal Rigidity, Palpitations, RED Blood Cell Count Decreased, Asthenia, Cough, Lethargy
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2012-02-07
Copegus
Indication: Hepatitis C
Start date: 2012-02-07
Copegus
Telaprevir
Indication: Hepatitis C
Start date: 2012-02-07
Possible Copegus side effects in female
Reported by a individual with unspecified qualification from United States on 2012-05-25
Patient: female, weighing 72.7 kg (159.9 pounds)
Reactions: Mania, Abdominal Pain, Dyspnoea, Nausea, Urinary Tract Infection, Pancreatic Cyst, Depression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Escitalopram Oxalate
Administration route: Oral
Indication: Depression
Start date: 2012-04-19
End date: 2012-04-21
Copegus
Dosage: 600 mg in every morning and 400 mg in every evening
Indication: Hepatitis C
Start date: 2011-11-10
End date: 2012-04-21
Pegasys
Indication: Hepatitis C
Start date: 2011-11-10
End date: 2012-04-18
Blinded Alisporivir
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-10
End date: 2012-04-17
Escitalopram Oxalate
End date: 2012-04-23
Possible Copegus side effects in female
Reported by a individual with unspecified qualification from United States on 2012-05-22
Patient: female, weighing 72.7 kg (159.9 pounds)
Reactions: Abdominal Pain, Mania, Dyspnoea, Nausea, Urinary Tract Infection, Pancreatic Cyst, Depression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2011-11-10
End date: 2012-04-18
Copegus
Dosage: 600 mg in every morning and 400 mg in every evening
Indication: Hepatitis C
Start date: 2011-11-10
End date: 2012-04-21
Escitalopram Oxalate
End date: 2012-04-23
Blinded Alisporivir
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-10
End date: 2012-04-17
Escitalopram Oxalate
Administration route: Oral
Indication: Depression
Start date: 2012-04-19
End date: 2012-04-21
Possible Copegus side effects in female
Reported by a consumer/non-health professional from United States on 2012-05-15
Patient: female
Reactions: Weight Decreased, Dyspnoea, PRE-Existing Condition Improved, Hypotension, Blood Count Abnormal, Dysgeusia, Eye Haemorrhage, Fatigue, Palpitations, Dehydration, Dizziness, Gingival Infection, White Blood Cell Count Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Copegus
Dosage: in divided doses, route, form: not reported
Indication: Hepatitis C
Start date: 2011-11-11
Telaprevir
Dosage: route: not reported
Indication: Hepatitis C
Start date: 2011-11-11
End date: 2012-01-20
Copegus
Dosage: divided doses, last injection on 20/apr/2012
End date: 2012-04-20
Pegasys
Dosage: route: not reported, last injection on 20/apr/2012
Indication: Hepatitis C
Start date: 2011-11-11
End date: 2012-04-20
Possible Copegus side effects in female
Reported by a consumer/non-health professional from United States on 2012-05-10
Patient: female
Reactions: White Blood Cell Count Decreased, Abdominal Pain, Chest Discomfort, Dyspnoea, Haemoglobin Abnormal, Abdominal Rigidity, RED Blood Cell Count Decreased, Palpitations, Cough, Lethargy
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2012-02-07
Copegus
Indication: Hepatitis C
Start date: 2012-02-07
Telaprevir
Indication: Hepatitis C
Start date: 2012-02-07
Possible Copegus side effects in female
Reported by a individual with unspecified qualification from United States on 2012-05-07
Patient: female
Reactions: Pneumonia, Dyspnoea, Disseminated Intravascular Coagulation, Anaemia, Pancytopenia, Abdominal Pain Upper, Fatigue, Mitral Valve Incompetence, Sepsis, Pleural Effusion, Cholecystitis, Hepatitis Toxic, Neutropenia, Blood Sodium Decreased, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Copegus
Indication: Hepatitis C
Start date: 2012-01-13
End date: 2012-02-11
Telaprevir
Indication: Hepatitis C
Start date: 2012-01-13
End date: 2012-02-11
Pegasys
Indication: Hepatitis C
Start date: 2012-01-13
End date: 2012-02-11
Other drugs received by patient: Trazodone HCL
Possible Copegus side effects in 53 year old female
Reported by a physician from France on 2012-05-03
Patient: 53 year old female
Reactions: Chills, Respiratory Alkalosis, Blood Culture Positive, Proteus Test Positive, Dizziness, Electrocardiogram T Wave Inversion, Renal Failure Acute, Decreased Appetite, Pyelonephritis, Cough, Back Pain, Dyspnoea, Hyponatraemia, Cystitis, Escherichia Test Positive, Lung Disorder, Fungal Test Positive, Sepsis, Normochromic Normocytic Anaemia, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Dosage: 180 mcg;qw;sc
Indication: Hepatitis C
Start date: 2011-09-26
End date: 2012-04-19
Victrelis
Dosage: 800 mg;tid
Indication: Hepatitis C
Start date: 2011-10-20
End date: 2012-04-18
Copegus
Dosage: 200 mg;tid
Indication: Hepatitis C
Start date: 2011-09-26
End date: 2012-04-19
Other drugs received by patient: Truvada; Isentress; Neorecormon
Page 1 Next >>
|